Working… Menu
Trial record 1 of 1 for:    CTX-471
Previous Study | Return to List | Next Study

Study of CTX-471 in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03881488
Recruitment Status : Recruiting
First Posted : March 19, 2019
Last Update Posted : July 30, 2021
Iqvia Pty Ltd
Information provided by (Responsible Party):
Compass Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : September 2022